[144] CompoSecure, Inc. SEC Filing
Rhea-AI Filing Summary
CompoSecure, Inc. (CMPO) filed a Form 144 notice for a proposed sale of 19,899 shares of Class A common stock on the NASDAQ through Merrill Lynch, with an aggregate market value of $383,293.75 and 102,378,638 shares outstanding. The shares were acquired and paid for on 08/13/2025 by exercise of employee stock options in a broker-assisted exercise. The filing reports "Nothing to Report" for sales in the past three months. The document does not provide the name of the selling person or identifying filer details in the visible content.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, routine insider option exercise and proposed sale; likely immaterial to valuation given size relative to outstanding shares.
The Form 144 documents a proposed sale of 19,899 shares valued at $383,293.75, representing a very small fraction of the 102,378,638 shares outstanding. The securities were acquired via exercise of employee stock options and immediately earmarked for broker-assisted sale through Merrill Lynch. There are no reported sales in the prior three months. Based solely on the filing, this appears to be a routine liquidity event rather than a signal of company-wide financial stress or material governance change.
TL;DR: Compliance notice consistent with Rule 144; missing filer identity limits context but filing itself is procedural.
The Form 144 provides the required notice for a proposed sale under Rule 144 and discloses acquisition method (employee option exercise) and broker details. It affirms no other sales in the prior three months. However, the filing as presented omits the seller's name and filer identifiers in the visible content, which constrains assessment of insider status or aggregation with other holdings. As presented, the record is a standard disclosure with limited material impact.